re: up again tomorrow Yes it was strange that sunday introduced both relenza and tamiflu and spent most of the report discussing tamiflu and the benefits/potential problems with it; i am perplexed why the reporter did not ask questions about relenza after introducing it as one of the two anti virals. At the very least you would discuss the positives and negatives of each of these.